Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC2A12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMCR8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SIDT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM106B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAPTM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABCG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAAF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC389641 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPHAR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIAPH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCNN1G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HJURP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WWC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAMBI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEK6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on